1-10 of 10
Michael Loken
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of 3346 patients from the combined Children's Oncology Group AML studies further characterizes RAM immunophenotype AML and reveals other associated phenotypes and genetic drivers.

Free
Andrew Menssen, Jacqueline Cook, Todd Alonzo, Robert Gerbing, Maria Pardo, Fan-Chi Hsu, Loren Lott, Fangyan Dai, Amenech Ashango, Thanh Thanh Dinh, Todd Cooper, Jessica Pollard, Katherine Tarlock, Lisa Brodersen, Michael Loken, Soheil Meshinchi, Chad Hudson
Journal: Blood
Blood (2025) 146 (Supplement 1): 337.
https://doi.org/10.1182/blood-2025-337
Published: 2025
Journal Articles

Initial results from a phase 2 study of cladribine, cytarabine, and granulocyte-colony stimulating factor with gemtuzumab ozogamicin (CLAG-GO) for the treatment of patients with relapsed/refractory acute myeloid leukemia

Free
David Chen, Maria Baer, Sandrine Niyongere, Ashkan Emadi, Vivek Shastri, Jatinder Lamba, Michael Loken, Larissa Sanglard, Rena Lapidus, Soren Bentzen, Vu Duong
Journal: Blood
Blood (2025) 146 (Supplement 1): 999.
https://doi.org/10.1182/blood-2025-999
Published: 2025
Journal Articles

FLT3 (CD135) expression in pediatric AML is associated with specific disease characteristics and worse outcome in the setting of sorafenib theraphy: A report from the Children's Oncology Group AAML1031 protocol.

Free
Andrew Menssen, Amenech Ashango, Todd Alonzo, Robert Gerbing, Maria Pardo, Fan-Chi Hsu, Loren Lott, Fangyan Dai, Todd Cooper, Jessica Pollard, Katherine Tarlock, Richard Aplenc, Soheil Meshinchi, Lisa Brodersen, Michael Loken, Chad Hudson
Journal: Blood
Blood (2025) 146 (Supplement 1): 5256.
https://doi.org/10.1182/blood-2025-5256
Published: 2025
Journal Articles

A novel intercontinental external quality assessment program for flow cytometric measurable residual disease assessment in pediatric AML

Free
Margarita Maurer-Granofszky, Flavia Battistutta, Boutheina Bouslama, Lisa Brodersen, Chad Hudson, Christel Katerkamp, Pamela Scarparo, Anastasia Soboli, Jeroen te Marvelde, Barbara Buldini, Linda Fogelstrand, David Gillis, Hélène Lapillonne, Michael Loken, Vincent van der Velden, Nils Von Neuhoff, Lucy Wheeler, Todd Cooper, Sarah Tasian, Dirk Reinhardt, Gwen Nichols, C. Zwaan, Michael Dworzak
Journal: Blood
Blood (2025) 146 (Supplement 1): 3514.
https://doi.org/10.1182/blood-2025-3514
Published: 2025
Journal Articles

Post-transplant maintenance with sorafenib is safe and effective in pediatric patients with har FLT3/ITD AML: A report from the Children's oncology group protocol AAML1031

Free
Caitlin Elgarten, Todd Alonzo, Robert Gerbing, John Choi, Brian Fisher, Betsy Hirsch, Samir Kahwash, John Levine, Lisa Brodersen, Michael Loken, Susana Raimondi, Katherine Tarlock, Andrew Wood, Lillian Sung, Todd Cooper, Alan Gamis, Soheil Meshinchi, Richard Aplenc, Jessica Pollard
Journal: Blood
Blood (2025) 146 (Supplement 1): 1644.
https://doi.org/10.1182/blood-2025-1644
Published: 2025
Journal Articles

Phase I study of FH FOLR1 CAR T for pediatric patients with FOLR1+/CBFA2T3::GLIS2+ relapsed or refractory Acute Myeloid Leukemia

Free
Katherine Tarlock, Corinne Summers, Danielle Kirkey, Rhonda Ries, Maria Pardo, Andrew Menssen, Chad Hudson, Folashade Otegbeye, Lara Kropp, Christy Greene, Stefanie Schmuck, Armenuhi Avanesyan, Concetta Quintarelli, Michael Loken, Franco Locatelli, Soheil Meshinchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 4176.
https://doi.org/10.1182/blood-2025-4176
Published: 2025
Journal Articles

High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial

Free
Clinical Trials & Observations
Johann Hitzler, Todd Alonzo, Robert Gerbing, Amy Beckman, Betsy Hirsch, Susana Raimondi, Karen Chisholm, Shelton Viola, Lisa Brodersen, Michael Loken, Spencer Tong, Todd Druley, Maureen O’Brien, Nobuko Hijiya, Amy Heerema-McKenney, Yi-Chang Wang, Reuven Shore, Jeffrey Taub, Alan Gamis, E. Anders Kolb, Jason N. Berman
Journal: Blood
Blood (2021) 138 (23): 2337–2346.
https://doi.org/10.1182/blood.2021012206
Published: 2021
Includes: Supplemental data
Journal Articles

Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML

Free
Clinical Trials & Observations
Jessica A. Pollard, Todd A. Alonzo, Michael Loken, Robert B. Gerbing, Phoenix A. Ho, Irwin D. Bernstein, Susana C. Raimondi, Betsy Hirsch, Janet Franklin, Roland B. Walter, Alan Gamis, Soheil Meshinchi
Journal: Blood
Blood (2012) 119 (16): 3705–3711.
https://doi.org/10.1182/blood-2011-12-398370
Published: 2012
Journal Articles

Minimal Residual Disease Detection by Four-Color Multidimensional Flow Cytometry Identifies Pediatric AML Patients at High Risk of Relapse.

Free
Soheil Meshinchi, MD, PhD, Todd Alonzo, PhD, Robert B. Gerbing, MA, Jessica A. Pollard, MD, Alan S. Gamis, MD, MPH, Craig A. Hurwitz, MD, Janet L. Franklin, MD, Laura Pardo, MD, Michael Loken, PhD
Journal: Blood
Blood (2007) 110 (11): 1429.
https://doi.org/10.1182/blood.V110.11.1429.1429
Published: 2007
Journal Articles

Long-term engraftment and clonal dominance of donor-derived del(20q) hematopoietic cells after allogeneic stem cell transplantation

Free
Marco Mielcarek, Eileen Bryant, Michael Loken, Jan Maciej Zaucha, Beverly Torok-Storb, Rainer Storb
Journal: Blood
Blood (2006) 107 (4): 1732–1733.
https://doi.org/10.1182/blood-2005-09-3781
Published: 2006